Common Shares Outstanding: The number of class A shares currently held by investors.
Sangamo Therapeutics, Inc. (SGMO) had Common Shares Outstanding of 350.69M for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
$39.55M |
|
$-122.93M |
|
-- |
|
$39.55M |
|
$160.79M |
|
$-121.24M |
|
$-2.26M |
|
$-123.50M |
|
$-123.50M |
|
$-122.93M |
|
$-122.93M |
|
$-122.93M |
|
$-122.93M |
|
$-121.24M |
|
$-113.64M |
|
280.19M |
|
280.19M |
|
$-0.44 |
|
$-0.44 |
|
| Balance Sheet Financials | |
$35.83M |
|
$11.04M |
|
$23.91M |
|
$59.74M |
|
$42.47M |
|
-- |
|
$31.55M |
|
$74.01M |
|
$-14.27M |
|
$-14.27M |
|
$-14.27M |
|
|
Common Shares Outstanding |
350.69M |
| Cash Flow Statement Financials | |
$-97.21M |
|
$-0.10M |
|
$70.75M |
|
$43.42M |
|
$20.95M |
|
$-22.47M |
|
$9.08M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.84 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-306.53% |
|
-306.53% |
|
-287.31% |
|
-312.25% |
|
-310.81% |
|
$-97.31M |
|
-- |
|
-- |
|
-- |
|
0.66 |
|
-- |
|
106.61 |
|
3.42 |
|
861.59% |
|
861.59% |
|
-205.76% |
|
861.59% |
|
$-0.04 |
|
$-0.35 |
|
$-0.35 |
|